Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
|
|
Chemours Co (CC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/01/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million WILMINGTON, Del., NASHVILLE, Tn, June 1, 2023 -- The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered into a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle market investments across the specialty industrial and healthcare sectors. With this acquisition, PureTech Scientific is positioning itself to become the global leader in organic synthesis of ultra-high purity alpha..." |
|
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/28/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials Business strategies are unchanged as the company promotes top executives Wilmington, Del., March 23, 2023 – The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announces the appointment of Denise Dignam as President, Chemours Titanium Technologies and Chemical Solutions, effective April 1, 2023. Chemours will promote Gerardo Familiar to succeed Ms. Dignam as President, Chemours Advanced Performance Materials. “Chemours is fortunate to have tremendous internal talent from which to draw in order to fill these key l..." |
|
| 03/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/10/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/10/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/10/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/14/2023 |
SC 13G/A
| Sessa Capital , L.P. reports a 0.5% stake in THE CHEMOURS COMPANY |
| 02/10/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/09/2023 |
8-K
| Quarterly results|
Docs:
|
"The Chemours Company Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook Delivered record annual results in TSS and APM driven by strong secular tailwinds Wilmington, Del., February 9, 2023 -- The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials today announced its financial results for the fourth quarter and full year 2022. Full Year 2022 Results • Net Sales of $6.8 billion, up 7% year-over-year • Net Income of $578 million with EPS1 of $3.65, up $0.05 year-over-year • Adjusted Net Income* of $738 million with Adjusted EPS* of $4.66, up $0.66 year-over-year • Adjusted EBITDA*of $1,361 million, up 4% year-over-ye..." |
|
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 12.3% stake in CHEMOURS COMPANY |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/27/2022 |
8-K/A
| Quarterly results |
|
|
|